Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry | Heart
Could aspirin intake reduce mortality risk in COVID-19 patients?
Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis | SpringerLink
Aspirin Use is Associated with Decreased Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis
Frontiers | Aspirin in COVID-19: Pros and Cons
Aspirin may reduce risk of severe COVID symptoms: Study
Neurology International | Free Full-Text | Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities
Pre-hospital Aspirin Use and Patient Outcomes in COVID-19: Results from the International Viral Infection and Respiratory Illness Universal Study (VIRUS) | Archivos de Bronconeumología
Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico - International Journal of Infectious Diseases
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial - The Lancet Respiratory Medicine
Post-acute COVID-19 syndrome | Nature Medicine
Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? | Drugs
Medicina | Free Full-Text | Aspirin Is Related to Worse Clinical Outcomes of COVID-19
Frontiers | Aspirin in COVID-19: Pros and Cons
Rationales and uncertainties for aspirin use in COVID-19: a narrative review | Family Medicine and Community Health
Frontiers | Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation
Full article: Low-dose aspirin for early COVID-19: does the early bird catch the worm?
Biomedicines | Free Full-Text | Aspirin and Infection: A Narrative Review
Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence- - International Journal of Cardiology
Frontiers | Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
Rapid implementation of mobile technology for real-time epidemiology of COVID-19 | Science
Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients? - Federico Cacciapuoti, Fulvio Cacciapuoti, 2021
Medicina | Free Full-Text | Aspirin Is Related to Worse Clinical Outcomes of COVID-19
Aspirin | C9H8O4 | CID 2244 - PubChem
To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial - British Journal of Anaesthesia
